Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Moderna: Reiterates Plan to Deliver up to 10% Revenue Growth in 2026

THOMSON REUTERS
·
Jul 31

Moderna: Expects About 55% of Its Second Half 2026 Revenue to be Recognized in the Third Quarter

THOMSON REUTERS
·
Jul 31

Moderna: in Second Half of 2026, Preparing for Potential Approval of Mflusiva in the U.S.

THOMSON REUTERS
·
Jul 31

Moderna: Anticipates Potential Approval of Moderna's 5TH Product with August 5TH Pdufa Date for Mflusiva

THOMSON REUTERS
·
Jul 31

Moderna: Mrna-1403 Did not Meet Statistical Criteria for Early Success at Phase 3 Interim Analysis, Preparing to Enroll Additional Cohort

THOMSON REUTERS
·
Jul 31

Moderna: Q2 REV $145 Mln

THOMSON REUTERS
·
Jul 31

Moderna: Expected 2026 Year-End Cash Balance to $4.7 Bln- $5.2 Bln

THOMSON REUTERS
·
Jul 31

Moderna Q2 EPS USD -1.97 VS. Ibes Estimate USD -2.08

THOMSON REUTERS
·
Jul 31

Moderna Outlook FY Capex USD 200-300 Million

THOMSON REUTERS
·
Jul 31

Corrected-Moderna Q2 Revenue USD 145 Million VS. Ibes Estimate USD 103 Million (Corrects Amount)

THOMSON REUTERS
·
Jul 31

Movement Alert|Moderna, Inc. Rises 5.03% in Regular Trading, Multiple Analyst Upgrades and Flu Vaccine Catalyst Ahead of Earnings

Market Focus
·
Jul 31

Stock Track | Moderna Soars 5.01% Intraday on Ebola Vaccine Trial Launch, Earnings Anticipation

Stock Track
·
Jul 31

Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?

TIPRANKS
·
Jul 31

Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch

TIPRANKS
·
Jul 31

US Fusion Energy Company Commonwealth Raises $1 Billion in Equity Funding

Reuters
·
Jul 30

Stock Track | Moderna Soars 5.20% Intraday on Goldman Sachs Target Hike and Flu Vaccine Optimism

Stock Track
·
Jul 27

Movement Alert|Moderna, Inc. Rises 5.15% in Regular Trading, Goldman Sachs Target Price Hike and Flu Vaccine Approval Expectations Fuel Rebound

Market Focus
·
Jul 27

Moderna Inc. Stock Falls 5.2%, Underperforms Peers

Dow Jones
·
Jul 25

Cboe data shows mixed options sentiment in Moderna with shares down 4.65%

TIPRANKS
·
Jul 25

Stock Track | Moderna Plunges 5.15% Intraday as Cautious Analyst Views and Q2 Earnings Jitters Mount

Stock Track
·
Jul 24